Reuters is reporting the U.S. Food and Drug Administration (F.D.A.) has granted full approval to the Pfizer Inc COVID-19 vaccine that had earned emergency-use authorization (EUA) in December, making it the first to secure such an F.D.A. validation.

The full approval marks a regulatory switch for Pfizer’s shot away from an experimental (EUA) therapy. The F.D.A.’s move was expected in early Fall but the timeline was fast-tracked potentially fueling the very ‘vaccine hesitancy’ government agencies are trying to eliminate.

The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty writes the F.D.A.. The shot is officially approved for Americans over the age of 16, while the EUA remains in effect for patients between 12 and 15.

The approval was telegraphed days earlier on Friday when “people familiar with the planning, who were not authorized to speak publicly about it” leaked the news to the New York Times causing shares of Pfizer stock to rise at Monday’s market opening.

Zerohedge is reporting:

Full approval opens the door to several activities that were barred under the emergency authorization: Pfizer can now advertise the jab, and it can now continue to vaccinate people even after the COVID “emergency” is deemed over. Pfizer can also now raise the price of the vaccine. They have already raised the price of the jab in the EU.

One of the first to seize on the full approval is the U.S. military who will move to mandate the COVID-19 vaccine for all service members now that the Pfizer vaccine has full approval. The Defense Department is preparing “guidance to the force” to make the vaccine mandatory, with a timeline to be provided in the coming days, Pentagon press secretary John Kirby told reporters. 

Previous EUA’s for both Pfizer, Moderna and J&J were greeted with customary public hearings held by the F.D.A. to review the science, allow for public comment before decisions were made and operate in full transparency. With Pfizer’s shot moving to market at record speed with boosters already announced, the lack of promised transparency by the F.D.A. has some worried that the decision was politically driven and may lower standards for future biologics license application approvals.

Last year the FDA said it was “committed to use an advisory committee composed of independent experts to ensure deliberations about authorisation or licensure are transparent for the public.” But in a statement, the FDA told The BMJ that it did not believe a meeting was necessary ahead of the expected granting of full approval.

Pfizer-BioNTech is now planning to quickly ask the F.D.A. to approve a third dose as a booster shot after the first two-shot series has been found stop neither infection or virus transmission in a growing percentage of recipients.

The medical community, as well as public health officials, have voiced their concern at the Biden administration’s announcement last week that fully vaccinated adults should prepare to get their booster shots eight months after they received their second doses beginning Sept. 20.

The public proclamation broke from basic scientific and regulatory processes by leapfrogging both the F.D.A. or the U.S. Centers for Disease Control and Prevention’s (C.D.C.) ACIP committee. In doing so, the Biden administration eliminated the chance for both bodies to meet and review data on the booster’s safety and efficacy in the adult populations.

Diana Zuckerman, president of the National Center for Health Research, who has also spoken at recent VRBPAC meetings, told The BMJ, “It’s obvious that the FDA has no intention of hearing anyone else’s opinion. But if you make decisions behind closed doors it can feed into hesitancy. It’s important to have a public discussion about what kind of data are there and what the limitations are. As we think about risk versus benefit, we need to know.”

Read the F.D.A.’s news release regarding the approval here:
https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine

Jefferey Jaxen

Jefferey Jaxen is a health journalist and featured in his weekly segment, ’The Jaxen Report’, on The HighWire. As an investigative journalist, researcher, and compelling writer, Jefferey serves as Lead editor of The HighWire News and Opinion Team.

Other Headlines

Coronavirus

ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

The Informed Consent Action Network (ICAN) and REACT 19 held a joint press conference today to reveal a trove of secret recordings and FOIA documents of Peter Marks, the former Director of the Center for Biologics Evaluation and Research. The press conference included ICAN Founder Del Bigtree, Attorney Aaron Siri, and REACT 19’s Brianne Dressen.Continue reading ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

More news about Coronavirus

Health & Nutrition

New Fluoride Study Ignores Neurotoxicity and Sugar Intake in Cost Analysis

A new fluoride study has been criticized for being a tool of the industry to promote continued water fluoridation following the banning of the practice in Utah and Florida. The authors conducted a simulation model and cost-effectiveness analysis with data from 8484 children with a mean age of 9.6 years. The authors concluded eliminating fluorideContinue reading New Fluoride Study Ignores Neurotoxicity and Sugar Intake in Cost Analysis

More news about Health & Nutrition

Vaccines

HHS Terminates Moderna Contract For Bird Flu Vaccine; Calls mRNA Technology “Under-Tested”

HHS has terminated a $766 million contract with Moderna to develop an mRNA bird flu vaccine. HHS spokesman Andrew Nixon said the decision is about “safety, integrity, and trust.” He added that “mRNA technology remains under-tested, and we are not going to spend taxpayer dollars repeating the mistakes of the last administration, which concealed legitimateContinue reading HHS Terminates Moderna Contract For Bird Flu Vaccine; Calls mRNA Technology “Under-Tested”

More news about Vaccines

Science & Tech

Humanoid Robots Malfunction and Attack; Sparks Debate Over AI Safety and Liability

A viral video released from an undisclosed Chinese factory shows a humanoid robot malfunctioning and attacking the factory workers. The Unitree H1, a product of the Chinese company Unitree Robotics, can be seen flailing its arms as workers move away to protect themselves. The robot was hung on a crane, and the workers were notContinue reading Humanoid Robots Malfunction and Attack; Sparks Debate Over AI Safety and Liability

More news about Science & Tech

Environment

CDC Advised Health Care Providers Not to Test East Palestine Residents for Chemical Illnesses, Lawsuit Alleges

Newsnation reported this week that the CDC advised local health care providers in East Palestine, OH, not to test local residents for chemical illnesses after the town was exposed to a toxic plume from a “controlled burn” after the Norfolk Southern train derailment in 2023. A lawsuit has been filed against Norfolk Southern and moreContinue reading CDC Advised Health Care Providers Not to Test East Palestine Residents for Chemical Illnesses, Lawsuit Alleges

More news about Environment

Policy

HHS and CMS Urge Changes to Gender-Affirming Care for Minors; Clinics Face Potential Loss of Federal Funding

HHS Secretary Robert F. Kennedy Jr. wrote a letter addressed to healthcare providers saying he expects them to update their “treatment protocols and training to ensure that care for children with gender dysphoria is evidence-based.” The letter was also addressed to healthcare risk managers and state medical boards. The letter refers to the report publishedContinue reading HHS and CMS Urge Changes to Gender-Affirming Care for Minors; Clinics Face Potential Loss of Federal Funding

More news about Policy